in ,

Aubameyang’s deadline day decision notified Arsenal

Aubameyang's deadline day decision notified Arsenal

Pierre-Emerick Aubameyang will decide on his future at Arsenal next June after months of speculation over his whereabouts. Aubameyang has decided against renewing his contract. Aubameyang’s deadline day decision notified Arsenal.

The former Gabon striker, who has a year left on his contract, does not agree to a contract extension and there seems to be little chance for Arsenal to persuade him to keep him at the Emirates.

Manager Mikel Arteta, who has been working on building a title and top-flight team in the coming years wants to keep Pierre-Emerick Aubameyang at the Emirates but there are fears this summer is the only option if they want him. They have to get money from the player they can sell if there is no agreement, so he will not be leaving on a free transfer next summer.

Both Real Madrid and Barcelona are keeping an eye on the player, and reports earlier this week claimed that Zinedine Zidane and his club had made direct contact with Pierre-Emerick Aubameyang and Arsenal in order to land the Spanish giants. .

According to the newspaper Sport, Pierre-Emerick Aubameyang has the final decision will tell Arsenal in June but it may be a bit delayed as Coronavirus disease is still the world’s fear of possible Premier League season to be completed later.

Real Madrid has struggled for goals this season, and Zidane sees Aubameyang as an easier target than Kylian Mbappe and Erling Haaland, who has been linked with the Santiago Bernabeu.


Pierre-Emerick Aubameyang bought Arsenal for £ 56 million from Borussia Dortmund in January 2018 and has since gone on to make 97 appearances, scoring 61 goals.

Last season, Premier League goalscorer Mohamed Salah and Sadio Mane all scored 22 goals.

What do you think?

135 points
Upvote Downvote
Zidane is looking for Casemiro substitute in the midfield

Zidane is looking for Casemiro substitute in the midfield

The breakthrough discovery

The breakthrough discovery PREVAIL EMULIN